XNAS 05 May, 2026 2:50 PM (EDT)
| Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|
| Herm Rosenman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Apr 2026 | 222 | 20,780 (0%) | 0% | - | Common Stock | |
| Herm Rosenman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Apr 2026 | 117 | 20,558 (0%) | 0% | - | Common Stock | |
| Ruth Williams Brinkley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Apr 2026 | 86 | 5,475 (0%) | 0% | - | Common Stock | |
| Roelof Frederik Botha | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Apr 2026 | 222 | 2,894 (0%) | 0% | - | Common Stock | |
| Roelof Frederik Botha | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Apr 2026 | 132 | 2,672 (0%) | 0% | - | Common Stock | |
| Roy D. Baynes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Apr 2026 | 83 | 18,512 (0%) | 0% | - | Common Stock | |
| Gail B. Marcus | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Apr 2026 | 222 | 6,183 (0%) | 0% | - | Common Stock | |
| Gail B. Marcus | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Apr 2026 | 108 | 5,961 (0%) | 0% | - | Common Stock | |
| Monica Bertagnolli | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Apr 2026 | 83 | 5,374 (0%) | 0% | - | Common Stock | |
| Rowan E. Chapman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Apr 2026 | 222 | 6,088 (0%) | 0% | - | Common Stock | |
| Rowan E. Chapman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Apr 2026 | 114 | 5,866 (0%) | 0% | - | Common Stock | |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 199.59 per share. | 17 Apr 2026 | 750 | 20,282 (0%) | 0% | 199.6 | 149,693 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 199.66 per share. | 17 Apr 2026 | 750 | 20,282 (0%) | 0% | 199.7 | 149,748 | Common Stock |
| Matthew Rabinowitz | Director, EXECUTIVE CHAIRMAN | Payment of exercise price or tax liability using portion of securities received from the company at price $ 204.87 per share. | 06 Apr 2026 | 27,610 | 2,383,162 (3%) | 0% | 204.9 | 5,656,461 | Common Stock |
| Matthew Rabinowitz | Director, EXECUTIVE CHAIRMAN | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.59 per share. | 06 Apr 2026 | 58,292 | 2,410,772 (3%) | 0% | 9.6 | 559,020 | Common Stock |
| Matthew Rabinowitz | Director, EXECUTIVE CHAIRMAN | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Apr 2026 | 58,292 | 0 | - | - | Stock Option (right to buy) | |
| Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | Sale of securities on an exchange or to another person at price $ 202.01 per share. | 01 Apr 2026 | 1,778 | 231,207 (0%) | 0% | 202.0 | 359,167 | Common Stock |
| Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | Sale of securities on an exchange or to another person at price $ 203.83 per share. | 01 Apr 2026 | 1,200 | 226,794 (0%) | 0% | 203.8 | 244,591 | Common Stock |
| Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | Sale of securities on an exchange or to another person at price $ 203.07 per share. | 01 Apr 2026 | 3,213 | 227,994 (0%) | 0% | 203.1 | 652,470 | Common Stock |
| Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | Sale of securities on an exchange or to another person at price $ 200.79 per share. | 01 Apr 2026 | 300 | 232,985 (0%) | 0% | 200.8 | 60,236 | Common Stock |
| Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | Sale of securities on an exchange or to another person at price $ 205.00 per share. | 01 Apr 2026 | 1,909 | 224,885 (0%) | 0% | 205.0 | 391,350 | Common Stock |
| Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | Sale of securities on an exchange or to another person at price $ 203.31 per share. | 01 Apr 2026 | 952 | 147,882 (0%) | 0% | 203.3 | 193,552 | Common Stock |
| Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | Sale of securities on an exchange or to another person at price $ 202.36 per share. | 01 Apr 2026 | 1,000 | 148,834 (0%) | 0% | 202.4 | 202,364 | Common Stock |
| Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | Sale of securities on an exchange or to another person at price $ 201.32 per share. | 01 Apr 2026 | 1,048 | 149,834 (0%) | 0% | 201.3 | 210,984 | Common Stock |
| Matthew Rabinowitz | Director, EXECUTIVE CHAIRMAN | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Mar 2026 | 41,708 | 58,292 | - | - | Stock Option (right to buy) | |
| Matthew Rabinowitz | Director, EXECUTIVE CHAIRMAN | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.59 per share. | 31 Mar 2026 | 41,708 | 2,352,480 (3%) | 0% | 9.6 | 399,980 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 196.27 per share. | 18 Mar 2026 | 300 | 262,025 (0%) | 0% | 196.3 | 58,880 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 198.85 per share. | 18 Mar 2026 | 239 | 21,543 (0%) | 0% | 198.9 | 47,526 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 199.82 per share. | 18 Mar 2026 | 140 | 21,403 (0%) | 0% | 199.8 | 27,975 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 200.97 per share. | 18 Mar 2026 | 371 | 21,032 (0%) | 0% | 201.0 | 74,561 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 198.49 per share. | 18 Mar 2026 | 235 | 21,547 (0%) | 0% | 198.5 | 46,644 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 199.88 per share. | 18 Mar 2026 | 235 | 21,312 (0%) | 0% | 199.9 | 46,971 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 200.90 per share. | 18 Mar 2026 | 280 | 21,032 (0%) | 0% | 200.9 | 56,253 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 198.65 per share. | 18 Mar 2026 | 1,814 | 259,255 (0%) | 0% | 198.7 | 360,355 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 197.84 per share. | 18 Mar 2026 | 956 | 261,069 (0%) | 0% | 197.8 | 189,135 | Common Stock |
| Rowan E. Chapman | Director | Sale of securities on an exchange or to another person at price $ 191.38 per share. | 13 Mar 2026 | 122 | 5,752 (0%) | 0% | 191.4 | 23,348 | Common Stock |
| Matthew Rabinowitz | Director, EXECUTIVE CHAIRMAN | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.59 per share. | 12 Mar 2026 | 75,000 | 2,385,772 (3%) | 0% | 9.6 | 719,250 | Common Stock |
| Matthew Rabinowitz | Director, EXECUTIVE CHAIRMAN | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Mar 2026 | 75,000 | 150,000 | - | - | Stock Option (right to buy) | |
| Matthew Rabinowitz | Director, EXECUTIVE CHAIRMAN | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Mar 2026 | 75,000 | 225,000 | - | - | Stock Option (right to buy) | |
| Matthew Rabinowitz | Director, EXECUTIVE CHAIRMAN | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Mar 2026 | 50,000 | 100,000 | - | - | Stock Option (right to buy) | |
| Matthew Rabinowitz | Director, EXECUTIVE CHAIRMAN | Sale of securities on an exchange or to another person at price $ 198.02 per share. | 12 Mar 2026 | 254 | 2,310,772 (2%) | 0% | 198.0 | 50,297 | Common Stock |
| Matthew Rabinowitz | Director, EXECUTIVE CHAIRMAN | Sale of securities on an exchange or to another person at price $ 197.22 per share. | 12 Mar 2026 | 16,457 | 2,311,026 (2%) | 0% | 197.2 | 3,245,612 | Common Stock |
| Matthew Rabinowitz | Director, EXECUTIVE CHAIRMAN | Sale of securities on an exchange or to another person at price $ 196.23 per share. | 12 Mar 2026 | 24,814 | 2,327,483 (2%) | 0% | 196.2 | 4,869,291 | Common Stock |
| Matthew Rabinowitz | Director, EXECUTIVE CHAIRMAN | Sale of securities on an exchange or to another person at price $ 195.42 per share. | 12 Mar 2026 | 4,875 | 2,352,297 (3%) | 0% | 195.4 | 952,696 | Common Stock |
| Matthew Rabinowitz | Director, EXECUTIVE CHAIRMAN | Sale of securities on an exchange or to another person at price $ 194.17 per share. | 12 Mar 2026 | 2,300 | 2,357,172 (3%) | 0% | 194.2 | 446,593 | Common Stock |
| Matthew Rabinowitz | Director, EXECUTIVE CHAIRMAN | Sale of securities on an exchange or to another person at price $ 192.43 per share. | 12 Mar 2026 | 900 | 2,359,472 (3%) | 0% | 192.4 | 173,185 | Common Stock |
| Matthew Rabinowitz | Director, EXECUTIVE CHAIRMAN | Sale of securities on an exchange or to another person at price $ 190.68 per share. | 12 Mar 2026 | 300 | 2,360,372 (3%) | 0% | 190.7 | 57,203 | Common Stock |
| Matthew Rabinowitz | Director, EXECUTIVE CHAIRMAN | Sale of securities on an exchange or to another person at price $ 190.07 per share. | 12 Mar 2026 | 100 | 2,360,672 (3%) | 0% | 190.1 | 19,007 | Common Stock |
| Matthew Rabinowitz | Director, EXECUTIVE CHAIRMAN | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.59 per share. | 12 Mar 2026 | 50,000 | 2,360,772 (3%) | 0% | 9.6 | 479,500 | Common Stock |
| Matthew Rabinowitz | Director, EXECUTIVE CHAIRMAN | Sale of securities on an exchange or to another person at price $ 191.22 per share. | 12 Mar 2026 | 1,100 | 2,310,772 (2%) | 0% | 191.2 | 210,345 | Common Stock |
| Matthew Rabinowitz | Director, EXECUTIVE CHAIRMAN | Sale of securities on an exchange or to another person at price $ 190.46 per share. | 12 Mar 2026 | 13,883 | 2,311,872 (2%) | 0% | 190.5 | 2,644,206 | Common Stock |
| Matthew Rabinowitz | Director, EXECUTIVE CHAIRMAN | Sale of securities on an exchange or to another person at price $ 189.50 per share. | 12 Mar 2026 | 21,504 | 2,325,755 (2%) | 0% | 189.5 | 4,075,006 | Common Stock |
| Matthew Rabinowitz | Director, EXECUTIVE CHAIRMAN | Sale of securities on an exchange or to another person at price $ 188.54 per share. | 12 Mar 2026 | 21,476 | 2,347,259 (2%) | 0% | 188.5 | 4,049,190 | Common Stock |
| Matthew Rabinowitz | Director, EXECUTIVE CHAIRMAN | Sale of securities on an exchange or to another person at price $ 187.63 per share. | 12 Mar 2026 | 17,037 | 2,368,735 (3%) | 0% | 187.6 | 3,196,632 | Common Stock |
| Matthew Rabinowitz | Director, EXECUTIVE CHAIRMAN | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.59 per share. | 12 Mar 2026 | 75,000 | 2,385,772 (3%) | 0% | 9.6 | 719,250 | Common Stock |
| Matthew Rabinowitz | Director, EXECUTIVE CHAIRMAN | Sale of securities on an exchange or to another person at price $ 195.32 per share. | 12 Mar 2026 | 100 | 2,310,772 (2%) | 0% | 195.3 | 19,532 | Common Stock |
| Matthew Rabinowitz | Director, EXECUTIVE CHAIRMAN | Sale of securities on an exchange or to another person at price $ 194.57 per share. | 12 Mar 2026 | 4,082 | 2,310,872 (2%) | 0% | 194.6 | 794,218 | Common Stock |
| Matthew Rabinowitz | Director, EXECUTIVE CHAIRMAN | Sale of securities on an exchange or to another person at price $ 193.58 per share. | 12 Mar 2026 | 7,043 | 2,314,954 (2%) | 0% | 193.6 | 1,363,389 | Common Stock |
| Matthew Rabinowitz | Director, EXECUTIVE CHAIRMAN | Sale of securities on an exchange or to another person at price $ 192.79 per share. | 12 Mar 2026 | 8,579 | 2,321,997 (2%) | 0% | 192.8 | 1,653,957 | Common Stock |
| Matthew Rabinowitz | Director, EXECUTIVE CHAIRMAN | Sale of securities on an exchange or to another person at price $ 191.55 per share. | 12 Mar 2026 | 9,896 | 2,330,576 (2%) | 0% | 191.6 | 1,895,595 | Common Stock |
| Matthew Rabinowitz | Director, EXECUTIVE CHAIRMAN | Sale of securities on an exchange or to another person at price $ 190.53 per share. | 12 Mar 2026 | 22,063 | 2,340,472 (2%) | 0% | 190.5 | 4,203,721 | Common Stock |
| Matthew Rabinowitz | Director, EXECUTIVE CHAIRMAN | Sale of securities on an exchange or to another person at price $ 189.64 per share. | 12 Mar 2026 | 2,886 | 2,362,535 (3%) | 0% | 189.6 | 547,307 | Common Stock |
| Matthew Rabinowitz | Director, EXECUTIVE CHAIRMAN | Sale of securities on an exchange or to another person at price $ 188.52 per share. | 12 Mar 2026 | 6,451 | 2,365,421 (3%) | 0% | 188.5 | 1,216,112 | Common Stock |
| Matthew Rabinowitz | Director, EXECUTIVE CHAIRMAN | Sale of securities on an exchange or to another person at price $ 187.52 per share. | 12 Mar 2026 | 5,809 | 2,371,872 (3%) | 0% | 187.5 | 1,089,300 | Common Stock |
| Matthew Rabinowitz | Director, EXECUTIVE CHAIRMAN | Sale of securities on an exchange or to another person at price $ 186.75 per share. | 12 Mar 2026 | 8,091 | 2,377,681 (3%) | 0% | 186.7 | 1,510,989 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Mar 2026 | 258 | 262,452 (0%) | 0% | - | Common Stock | |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 204.13 per share. | 09 Mar 2026 | 127 | 262,325 (0%) | 0% | 204.1 | 25,925 | Common Stock |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Mar 2026 | 1,968 | 64,139 (0%) | 0% | - | Common Stock | |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 204.13 per share. | 09 Mar 2026 | 785 | 63,354 (0%) | 0% | 204.1 | 160,244 | Common Stock |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Mar 2026 | 5,623 | 162,230 (0%) | 0% | - | Common Stock | |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Sale of securities on an exchange or to another person at price $ 204.13 per share. | 09 Mar 2026 | 5,623 | 156,607 (0%) | 0% | 204.1 | 1,147,838 | Common Stock |
| Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Mar 2026 | 1,745 | 235,030 (0%) | 0% | - | Common Stock | |
| Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | Sale of securities on an exchange or to another person at price $ 204.13 per share. | 09 Mar 2026 | 1,745 | 233,285 (0%) | 0% | 204.1 | 356,212 | Common Stock |
| Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Mar 2026 | 1,774 | 151,797 (0%) | 0% | - | Common Stock | |
| Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | Sale of securities on an exchange or to another person at price $ 204.13 per share. | 09 Mar 2026 | 915 | 150,882 (0%) | 0% | 204.1 | 186,781 | Common Stock |
| John Fesko | PRESIDENT, CHIEF BUS. OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Mar 2026 | 1,774 | 189,906 (0%) | 0% | - | Common Stock | |
| John Fesko | PRESIDENT, CHIEF BUS. OFFICER | Sale of securities on an exchange or to another person at price $ 204.13 per share. | 09 Mar 2026 | 707 | 189,199 (0%) | 0% | 204.1 | 144,322 | Common Stock |
| Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 19.68 per share. | 06 Mar 2026 | 5,598 | 241,683 (0%) | 0% | 19.7 | 110,169 | Common Stock |
| Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | Sale of securities on an exchange or to another person at price $ 196.94 per share. | 06 Mar 2026 | 1,500 | 235,283 (0%) | 0% | 196.9 | 295,406 | Common Stock |
| Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | Sale of securities on an exchange or to another person at price $ 198.05 per share. | 06 Mar 2026 | 1,998 | 233,285 (0%) | 0% | 198.0 | 395,694 | Common Stock |
| Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2026 | 5,598 | 0 | - | - | Stock Option (Right to Buy) | |
| Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | Sale of securities on an exchange or to another person at price $ 195.80 per share. | 06 Mar 2026 | 1,600 | 236,783 (0%) | 0% | 195.8 | 313,273 | Common Stock |
| Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | Sale of securities on an exchange or to another person at price $ 194.77 per share. | 06 Mar 2026 | 2,900 | 238,383 (0%) | 0% | 194.8 | 564,832 | Common Stock |
| Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | Sale of securities on an exchange or to another person at price $ 193.73 per share. | 06 Mar 2026 | 400 | 241,283 (0%) | 0% | 193.7 | 77,491 | Common Stock |
| Matthew Rabinowitz | Director, EXECUTIVE CHAIRMAN | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2026 | 29,920 | 2,310,772 (2%) | 0% | - | Common Stock | |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 198.50 per share. | 27 Feb 2026 | 470 | 264,794 (0%) | 0% | 198.5 | 93,293 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 200.42 per share. | 27 Feb 2026 | 2,400 | 262,394 (0%) | 0% | 200.4 | 481,012 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 201.20 per share. | 27 Feb 2026 | 100 | 262,294 (0%) | 0% | 201.2 | 20,120 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 202.85 per share. | 27 Feb 2026 | 100 | 262,194 (0%) | 0% | 202.9 | 20,285 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2026 | 2,103 | 265,264 (0%) | 0% | - | Common Stock | |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2026 | 10,051 | 62,171 (0%) | 0% | - | Common Stock | |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2026 | 37,401 | 160,557 (0%) | 0% | - | Common Stock | |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Sale of securities on an exchange or to another person at price $ 201.18 per share. | 27 Feb 2026 | 365 | 156,607 (0%) | 0% | 201.2 | 73,429 | Common Stock |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Sale of securities on an exchange or to another person at price $ 200.24 per share. | 27 Feb 2026 | 2,463 | 156,972 (0%) | 0% | 200.2 | 493,193 | Common Stock |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Sale of securities on an exchange or to another person at price $ 199.17 per share. | 27 Feb 2026 | 1,122 | 159,435 (0%) | 0% | 199.2 | 223,473 | Common Stock |
| Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2026 | 12,272 | 236,085 (0%) | 0% | - | Common Stock | |
| Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2026 | 10,051 | 147,898 (0%) | 0% | - | Common Stock | |
| Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | Sale of securities on an exchange or to another person at price $ 200.97 per share. | 27 Feb 2026 | 475 | 150,023 (0%) | 0% | 201.0 | 95,460 | Common Stock |
| Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | Sale of securities on an exchange or to another person at price $ 200.11 per share. | 27 Feb 2026 | 1,594 | 150,498 (0%) | 0% | 200.1 | 318,971 | Common Stock |
| Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Feb 2026 | 5,125 | 0 | - | - | Stock Option (right to buy) | |
| Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | Sale of securities on an exchange or to another person at price $ 198.83 per share. | 27 Feb 2026 | 931 | 152,092 (0%) | 0% | 198.8 | 185,114 | Common Stock |
| Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.59 per share. | 27 Feb 2026 | 5,125 | 153,023 (0%) | 0% | 9.6 | 49,149 | Common Stock |
| John Fesko | PRESIDENT, CHIEF BUS. OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2026 | 10,051 | 188,132 (0%) | 0% | - | Common Stock | |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 230.77 per share. | 03 Feb 2026 | 435 | 263,161 (0%) | 0% | 230.8 | 100,384 | Common Stock |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 225.25 per share. | 03 Feb 2026 | 700 | 57,091 (0%) | 0% | 225.2 | 157,674 | Common Stock |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 227.45 per share. | 03 Feb 2026 | 4,971 | 52,120 (0%) | 0% | 227.4 | 1,130,639 | Common Stock |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 230.77 per share. | 03 Feb 2026 | 1,268 | 57,791 (0%) | 0% | 230.8 | 292,614 | Common Stock |
| Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | Sale of securities on an exchange or to another person at price $ 230.77 per share. | 03 Feb 2026 | 1,334 | 223,813 (0%) | 0% | 230.8 | 307,845 | Common Stock |
| John Fesko | PRESIDENT, CHIEF BUS. OFFICER | Sale of securities on an exchange or to another person at price $ 231.14 per share. | 03 Feb 2026 | 2,415 | 178,081 (0%) | 0% | 231.1 | 558,203 | Common Stock |
| John Fesko | PRESIDENT, CHIEF BUS. OFFICER | Sale of securities on an exchange or to another person at price $ 230.77 per share. | 03 Feb 2026 | 1,179 | 180,496 (0%) | 0% | 230.8 | 272,075 | Common Stock |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Sale of securities on an exchange or to another person at price $ 230.95 per share. | 02 Feb 2026 | 20,079 | 144,623 (0%) | 0% | 230.9 | 4,637,173 | Common Stock |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Sale of securities on an exchange or to another person at price $ 229.08 per share. | 02 Feb 2026 | 6,631 | 206,549 (0%) | 0% | 229.1 | 1,519,060 | Common Stock |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Sale of securities on an exchange or to another person at price $ 230.77 per share. | 02 Feb 2026 | 4,725 | 123,156 (0%) | 0% | 230.8 | 1,090,379 | Common Stock |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Sale of securities on an exchange or to another person at price $ 234.00 per share. | 02 Feb 2026 | 100 | 127,881 (0%) | 0% | 234 | 23,400 | Common Stock |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Sale of securities on an exchange or to another person at price $ 233.31 per share. | 02 Feb 2026 | 7,445 | 127,981 (0%) | 0% | 233.3 | 1,737,006 | Common Stock |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Sale of securities on an exchange or to another person at price $ 232.41 per share. | 02 Feb 2026 | 9,197 | 135,426 (0%) | 0% | 232.4 | 2,137,444 | Common Stock |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Sale of securities on an exchange or to another person at price $ 230.03 per share. | 02 Feb 2026 | 41,847 | 164,702 (0%) | 0% | 230.0 | 9,625,957 | Common Stock |
| Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | Sale of securities on an exchange or to another person at price $ 228.50 per share. | 02 Feb 2026 | 80 | 142,406 (0%) | 0% | 228.5 | 18,280 | Common Stock |
| Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | Sale of securities on an exchange or to another person at price $ 230.77 per share. | 02 Feb 2026 | 1,639 | 137,847 (0%) | 0% | 230.8 | 378,229 | Common Stock |
| Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | Sale of securities on an exchange or to another person at price $ 234.00 per share. | 02 Feb 2026 | 16 | 139,486 (0%) | 0% | 234 | 3,744 | Common Stock |
| Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | Sale of securities on an exchange or to another person at price $ 233.24 per share. | 02 Feb 2026 | 600 | 139,502 (0%) | 0% | 233.2 | 139,942 | Common Stock |
| Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | Sale of securities on an exchange or to another person at price $ 232.33 per share. | 02 Feb 2026 | 850 | 140,102 (0%) | 0% | 232.3 | 197,477 | Common Stock |
| Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | Sale of securities on an exchange or to another person at price $ 230.84 per share. | 02 Feb 2026 | 576 | 140,952 (0%) | 0% | 230.8 | 132,964 | Common Stock |
| Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | Sale of securities on an exchange or to another person at price $ 229.96 per share. | 02 Feb 2026 | 878 | 141,528 (0%) | 0% | 230.0 | 201,903 | Common Stock |
| Herm Rosenman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jan 2026 | 99 | 20,441 (0%) | 0% | - | Common Stock | |
| Ruth Williams Brinkley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jan 2026 | 73 | 5,389 (0%) | 0% | - | Common Stock | |
| Roelof Frederik Botha | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jan 2026 | 112 | 2,540 (0%) | 0% | - | Common Stock | |
| Roy D. Baynes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jan 2026 | 70 | 18,429 (0%) | 0% | - | Common Stock | |
| Gail B. Marcus | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jan 2026 | 91 | 5,853 (0%) | 0% | - | Common Stock | |
| Monica Bertagnolli | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jan 2026 | 70 | 5,291 (0%) | 0% | - | Common Stock | |
| Rowan E. Chapman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jan 2026 | 97 | 5,874 (0%) | 0% | - | Common Stock | |
| John Fesko | PRESIDENT, CHIEF BUS. OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jan 2026 | 6,135 | 181,675 (0%) | 0% | - | Common Stock | |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 240.53 per share. | 27 Jan 2026 | 291 | 263,787 (0%) | 0% | 240.5 | 69,995 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 237.66 per share. | 27 Jan 2026 | 191 | 263,596 (0%) | 0% | 237.7 | 45,394 | Common Stock |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 240.53 per share. | 27 Jan 2026 | 784 | 63,339 (0%) | 0% | 240.5 | 188,577 | Common Stock |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 230.92 per share. | 27 Jan 2026 | 876 | 59,059 (0%) | 0% | 230.9 | 202,289 | Common Stock |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 229.94 per share. | 27 Jan 2026 | 991 | 59,935 (0%) | 0% | 229.9 | 227,866 | Common Stock |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 237.44 per share. | 27 Jan 2026 | 1,176 | 60,926 (0%) | 0% | 237.4 | 279,233 | Common Stock |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 237.66 per share. | 27 Jan 2026 | 1,237 | 62,102 (0%) | 0% | 237.7 | 293,988 | Common Stock |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Sale of securities on an exchange or to another person at price $ 240.53 per share. | 27 Jan 2026 | 2,322 | 216,828 (0%) | 0% | 240.5 | 558,514 | Common Stock |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Sale of securities on an exchange or to another person at price $ 237.66 per share. | 27 Jan 2026 | 3,648 | 213,180 (0%) | 0% | 237.7 | 866,992 | Common Stock |
| Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | Sale of securities on an exchange or to another person at price $ 240.53 per share. | 27 Jan 2026 | 886 | 226,147 (0%) | 0% | 240.5 | 213,111 | Common Stock |
| Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | Sale of securities on an exchange or to another person at price $ 237.66 per share. | 27 Jan 2026 | 1,000 | 225,147 (0%) | 0% | 237.7 | 237,662 | Common Stock |
| Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | Sale of securities on an exchange or to another person at price $ 240.53 per share. | 27 Jan 2026 | 1,013 | 143,686 (0%) | 0% | 240.5 | 243,658 | Common Stock |
| Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | Sale of securities on an exchange or to another person at price $ 237.66 per share. | 27 Jan 2026 | 1,200 | 142,486 (0%) | 0% | 237.7 | 285,195 | Common Stock |
| John Fesko | PRESIDENT, CHIEF BUS. OFFICER | Sale of securities on an exchange or to another person at price $ 237.66 per share. | 27 Jan 2026 | 928 | 175,540 (0%) | 0% | 237.7 | 220,551 | Common Stock |
| John Fesko | PRESIDENT, CHIEF BUS. OFFICER | Sale of securities on an exchange or to another person at price $ 240.53 per share. | 27 Jan 2026 | 784 | 176,468 (0%) | 0% | 240.5 | 188,577 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 244.87 per share. | 23 Jan 2026 | 390 | 21,782 (0%) | 0% | 244.9 | 95,500 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 243.59 per share. | 23 Jan 2026 | 160 | 22,172 (0%) | 0% | 243.6 | 38,974 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 242.23 per share. | 23 Jan 2026 | 200 | 22,332 (0%) | 0% | 242.2 | 48,446 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 245.62 per share. | 23 Jan 2026 | 50 | 21,782 (0%) | 0% | 245.6 | 12,281 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 244.78 per share. | 23 Jan 2026 | 355 | 21,832 (0%) | 0% | 244.8 | 86,897 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 243.49 per share. | 23 Jan 2026 | 185 | 22,187 (0%) | 0% | 243.5 | 45,046 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 242.31 per share. | 23 Jan 2026 | 160 | 22,372 (0%) | 0% | 242.3 | 38,770 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 234.12 per share. | 20 Jan 2026 | 2,470 | 264,678 (0%) | 0% | 234.1 | 578,266 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 235.00 per share. | 20 Jan 2026 | 93 | 267,148 (0%) | 0% | 235 | 21,855 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2026 | 191 | 267,241 (0%) | 0% | - | Common Stock | |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 234.74 per share. | 20 Jan 2026 | 2,981 | 267,050 (0%) | 0% | 234.7 | 699,755 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2026 | 191 | 0 | - | - | Restricted Stock Unit | |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 235.82 per share. | 20 Jan 2026 | 600 | 264,078 (0%) | 0% | 235.8 | 141,491 | Common Stock |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2026 | 1,522 | 0 | - | - | Restricted Stock Unit | |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 242.67 per share. | 20 Jan 2026 | 36,573 | 64,123 (0%) | 0% | 242.7 | 8,875,115 | Common Stock |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 235.00 per share. | 20 Jan 2026 | 602 | 100,696 (0%) | 0% | 235 | 141,470 | Common Stock |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2026 | 1,522 | 101,298 (0%) | 0% | - | Common Stock | |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 234.74 per share. | 20 Jan 2026 | 23,948 | 99,776 (0%) | 0% | 234.7 | 5,621,515 | Common Stock |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2026 | 3,386 | 0 | - | - | Restricted Stock Unit | |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Sale of securities on an exchange or to another person at price $ 234.74 per share. | 20 Jan 2026 | 71,932 | 217,354 (0%) | 0% | 234.7 | 16,885,203 | Common Stock |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2026 | 3,386 | 220,740 (0%) | 0% | - | Common Stock | |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Sale of securities on an exchange or to another person at price $ 235.00 per share. | 20 Jan 2026 | 1,590 | 219,150 (0%) | 0% | 235 | 373,650 | Common Stock |
| Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | Sale of securities on an exchange or to another person at price $ 234.74 per share. | 20 Jan 2026 | 19,234 | 226,615 (0%) | 0% | 234.7 | 4,514,958 | Common Stock |
| Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2026 | 856 | 0 | - | - | Restricted Stock Unit | |
| Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | Sale of securities on an exchange or to another person at price $ 235.00 per share. | 20 Jan 2026 | 438 | 227,033 (0%) | 0% | 235 | 102,930 | Common Stock |
| Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2026 | 856 | 227,471 (0%) | 0% | - | Common Stock | |
| Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | Sale of securities on an exchange or to another person at price $ 234.74 per share. | 20 Jan 2026 | 23,205 | 144,992 (0%) | 0% | 234.7 | 5,447,105 | Common Stock |
| Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | Sale of securities on an exchange or to another person at price $ 235.00 per share. | 20 Jan 2026 | 293 | 144,699 (0%) | 0% | 235 | 68,855 | Common Stock |
| John Fesko | PRESIDENT, CHIEF BUS. OFFICER | Sale of securities on an exchange or to another person at price $ 235.00 per share. | 20 Jan 2026 | 339 | 177,252 (0%) | 0% | 235 | 79,665 | Common Stock |
| John Fesko | PRESIDENT, CHIEF BUS. OFFICER | Sale of securities on an exchange or to another person at price $ 234.74 per share. | 20 Jan 2026 | 17,806 | 177,591 (0%) | 0% | 234.7 | 4,179,752 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jan 2026 | 7,450 | 270,031 (0%) | 0% | 0 | Common Stock | |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jan 2026 | 59,596 | 123,722 (0%) | 0% | 0 | Common Stock | |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jan 2026 | 152,718 | 289,286 (0%) | 0% | 0 | Common Stock | |
| Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jan 2026 | 37,248 | 245,849 (0%) | 0% | 0 | Common Stock | |
| Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jan 2026 | 44,698 | 168,197 (0%) | 0% | 0 | Common Stock | |
| John Fesko | PRESIDENT, CHIEF BUS. OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jan 2026 | 44,698 | 195,397 (0%) | 0% | 0 | Common Stock | |
| Jonathan Sheena | Director, CO-FOUNDER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.59 per share. | 05 Jan 2026 | 39,615 | 262,581 (0%) | 0% | 9.6 | 379,908 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2026 | 39,615 | 0 | - | - | Stock Option (right to buy) | |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Sale of securities on an exchange or to another person at price $ 229.67 per share. | 02 Jan 2026 | 1,634 | 136,568 (0%) | 0% | 229.7 | 375,283 | Common Stock |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Sale of securities on an exchange or to another person at price $ 228.64 per share. | 02 Jan 2026 | 2,214 | 138,202 (0%) | 0% | 228.6 | 506,198 | Common Stock |
| Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | Sale of securities on an exchange or to another person at price $ 228.33 per share. | 02 Jan 2026 | 1,292 | 125,158 (0%) | 0% | 228.3 | 295,002 | Common Stock |
| Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | Sale of securities on an exchange or to another person at price $ 229.43 per share. | 02 Jan 2026 | 1,659 | 123,499 (0%) | 0% | 229.4 | 380,620 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 224.90 per share. | 19 Dec 2025 | 200 | 23,082 (0%) | 0% | 224.9 | 44,979 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 226.36 per share. | 19 Dec 2025 | 550 | 22,532 (0%) | 0% | 226.4 | 124,498 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 224.74 per share. | 19 Dec 2025 | 200 | 23,082 (0%) | 0% | 224.7 | 44,948 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 226.34 per share. | 19 Dec 2025 | 550 | 22,532 (0%) | 0% | 226.3 | 124,489 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Gift of securities by or to the insider at price $ 0.00 per share. | 15 Dec 2025 | 1,060 | 226,036 (0%) | 0% | 0 | Common Stock | |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 227.44 per share. | 15 Dec 2025 | 1,348 | 223,096 (0%) | 0% | 227.4 | 306,583 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 228.28 per share. | 15 Dec 2025 | 130 | 222,966 (0%) | 0% | 228.3 | 29,677 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 226.54 per share. | 15 Dec 2025 | 1,592 | 224,444 (0%) | 0% | 226.5 | 360,652 | Common Stock |
| Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | Sale of securities on an exchange or to another person at price $ 230.76 per share. | 12 Dec 2025 | 4,692 | 113,065 (0%) | 0% | 230.8 | 1,082,714 | Common Stock |
| Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Dec 2025 | 22,376 | 5,125 | - | - | Stock Option (right to buy) | |
| Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | Gift of securities by or to the insider at price $ 0.00 per share. | 12 Dec 2025 | 115 | 126,450 (0%) | 0% | 0 | Common Stock | |
| Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.59 per share. | 12 Dec 2025 | 13,500 | 126,565 (0%) | 0% | 9.6 | 129,465 | Common Stock |
| Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.59 per share. | 12 Dec 2025 | 8,876 | 117,757 (0%) | 0% | 9.6 | 85,121 | Common Stock |
| Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | Gift of securities by or to the insider at price $ 0.00 per share. | 12 Dec 2025 | 180 | 108,881 (0%) | 0% | 0 | Common Stock | |
| Jonathan Sheena | Director, CO-FOUNDER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.29 per share. | 09 Dec 2025 | 4,436 | 227,096 (0%) | 0% | 9.3 | 41,210 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Dec 2025 | 4,436 | 5,544 | - | - | Stock Option (right to buy) | |
| Rowan E. Chapman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 32.15 per share. | 05 Dec 2025 | 4,000 | 10,143 (0%) | 0% | 32.2 | 128,600 | Common Stock |
| Rowan E. Chapman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Dec 2025 | 4,000 | 7,000 | - | - | Stock Option (right to buy) | |
| Rowan E. Chapman | Director | Sale of securities on an exchange or to another person at price $ 243.39 per share. | 05 Dec 2025 | 366 | 5,777 (0%) | 0% | 243.4 | 89,081 | Common Stock |
| Rowan E. Chapman | Director | Sale of securities on an exchange or to another person at price $ 243.08 per share. | 05 Dec 2025 | 4,000 | 6,143 (0%) | 0% | 243.1 | 972,308 | Common Stock |
| Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Dec 2025 | 6,902 | 5,598 | - | - | Stock Option (Right to Buy) | |
| Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 19.68 per share. | 04 Dec 2025 | 6,902 | 208,601 (0%) | 0% | 19.7 | 135,831 | Common Stock |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Sale of securities on an exchange or to another person at price $ 239.44 per share. | 01 Dec 2025 | 956 | 140,416 (0%) | 0% | 239.4 | 228,902 | Common Stock |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Sale of securities on an exchange or to another person at price $ 238.13 per share. | 01 Dec 2025 | 2,050 | 141,372 (0%) | 0% | 238.1 | 488,158 | Common Stock |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Sale of securities on an exchange or to another person at price $ 237.05 per share. | 01 Dec 2025 | 1,394 | 143,422 (0%) | 0% | 237.0 | 330,442 | Common Stock |
| Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | Sale of securities on an exchange or to another person at price $ 239.53 per share. | 01 Dec 2025 | 474 | 109,061 (0%) | 0% | 239.5 | 113,535 | Common Stock |
| Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | Sale of securities on an exchange or to another person at price $ 237.23 per share. | 01 Dec 2025 | 749 | 111,312 (0%) | 0% | 237.2 | 177,683 | Common Stock |
| Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | Sale of securities on an exchange or to another person at price $ 237.77 per share. | 01 Dec 2025 | 250 | 111,062 (0%) | 0% | 237.8 | 59,443 | Common Stock |
| Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | Sale of securities on an exchange or to another person at price $ 238.24 per share. | 01 Dec 2025 | 1,527 | 109,535 (0%) | 0% | 238.2 | 363,797 | Common Stock |
| Roelof Frederik Botha | Director | Sale of securities on an exchange or to another person at price $ 238.57 per share. | 24 Nov 2025 | 18,839 | 1,154,698 (1%) | 0% | 238.6 | 4,494,418 | Common Stock |
| Roelof Frederik Botha | Director | Sale of securities on an exchange or to another person at price $ 236.54 per share. | 24 Nov 2025 | 6,173 | 1,188,873 (1%) | 0% | 236.5 | 1,460,149 | Common Stock |
| Roelof Frederik Botha | Director | Sale of securities on an exchange or to another person at price $ 235.65 per share. | 24 Nov 2025 | 9,623 | 1,195,046 (1%) | 0% | 235.7 | 2,267,671 | Common Stock |
| Roelof Frederik Botha | Director | Sale of securities on an exchange or to another person at price $ 234.55 per share. | 24 Nov 2025 | 9,991 | 1,204,669 (1%) | 0% | 234.6 | 2,343,401 | Common Stock |
| Roelof Frederik Botha | Director | Sale of securities on an exchange or to another person at price $ 233.66 per share. | 24 Nov 2025 | 7,032 | 1,214,660 (1%) | 0% | 233.7 | 1,643,098 | Common Stock |
| Roelof Frederik Botha | Director | Sale of securities on an exchange or to another person at price $ 239.11 per share. | 24 Nov 2025 | 500 | 1,154,198 (1%) | 0% | 239.1 | 119,555 | Common Stock |
| Roelof Frederik Botha | Director | Sale of securities on an exchange or to another person at price $ 232.75 per share. | 24 Nov 2025 | 3,606 | 1,221,692 (1%) | 0% | 232.8 | 839,308 | Common Stock |
| Roelof Frederik Botha | Director | Sale of securities on an exchange or to another person at price $ 231.23 per share. | 24 Nov 2025 | 900 | 1,225,298 (1%) | 0% | 231.2 | 208,110 | Common Stock |
| Roelof Frederik Botha | Director | Sale of securities on an exchange or to another person at price $ 230.03 per share. | 24 Nov 2025 | 1,000 | 1,226,198 (1%) | 0% | 230.0 | 230,030 | Common Stock |
| Roelof Frederik Botha | Director | Sale of securities on an exchange or to another person at price $ 228.97 per share. | 24 Nov 2025 | 2,000 | 1,227,198 (1%) | 0% | 229.0 | 457,934 | Common Stock |
| Roelof Frederik Botha | Director | Sale of securities on an exchange or to another person at price $ 237.69 per share. | 24 Nov 2025 | 15,336 | 1,173,537 (1%) | 0% | 237.7 | 3,645,260 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 230.01 per share. | 20 Nov 2025 | 2,000 | 23,282 (0%) | 0% | 230.0 | 460,011 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 225.08 per share. | 20 Nov 2025 | 10,000 | 222,660 (0%) | 0% | 225.1 | 2,250,816 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 230.01 per share. | 20 Nov 2025 | 2,000 | 23,282 (0%) | 0% | 230.0 | 460,019 | Common Stock |
| Roy D. Baynes | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Nov 2025 | 5,112 | 600 | - | - | Stock Option (right to buy) | |
| Roy D. Baynes | Director | Sale of securities on an exchange or to another person at price $ 224.89 per share. | 19 Nov 2025 | 1,884 | 18,359 (0%) | 0% | 224.9 | 423,685 | Common Stock |
| Roy D. Baynes | Director | Sale of securities on an exchange or to another person at price $ 223.90 per share. | 19 Nov 2025 | 1,900 | 20,243 (0%) | 0% | 223.9 | 425,417 | Common Stock |
| Roy D. Baynes | Director | Sale of securities on an exchange or to another person at price $ 222.90 per share. | 19 Nov 2025 | 1,800 | 22,143 (0%) | 0% | 222.9 | 401,220 | Common Stock |
| Roy D. Baynes | Director | Sale of securities on an exchange or to another person at price $ 221.81 per share. | 19 Nov 2025 | 900 | 23,943 (0%) | 0% | 221.8 | 199,632 | Common Stock |
| Roy D. Baynes | Director | Sale of securities on an exchange or to another person at price $ 220.14 per share. | 19 Nov 2025 | 1,184 | 24,843 (0%) | 0% | 220.1 | 260,646 | Common Stock |
| Roy D. Baynes | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 41.19 per share. | 19 Nov 2025 | 7,068 | 26,027 (0%) | 0% | 41.2 | 291,131 | Common Stock |
| Roy D. Baynes | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 40.93 per share. | 19 Nov 2025 | 600 | 18,959 (0%) | 0% | 40.9 | 24,558 | Common Stock |
| Roy D. Baynes | Director | Sale of securities on an exchange or to another person at price $ 216.07 per share. | 19 Nov 2025 | 2,135 | 18,359 (0%) | 0% | 216.1 | 461,304 | Common Stock |
| Roy D. Baynes | Director | Sale of securities on an exchange or to another person at price $ 214.79 per share. | 19 Nov 2025 | 1,727 | 20,494 (0%) | 0% | 214.8 | 370,946 | Common Stock |
| Roy D. Baynes | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 40.93 per share. | 19 Nov 2025 | 5,112 | 23,471 (0%) | 0% | 40.9 | 209,234 | Common Stock |
| Roy D. Baynes | Director | Sale of securities on an exchange or to another person at price $ 213.47 per share. | 19 Nov 2025 | 1,250 | 22,221 (0%) | 0% | 213.5 | 266,839 | Common Stock |
| Roy D. Baynes | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Nov 2025 | 7,068 | 0 | - | - | Stock Option (right to buy) | |
| Roy D. Baynes | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Nov 2025 | 600 | 0 | - | - | Stock Option (right to buy) | |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 190.33 per share. | 07 Nov 2025 | 1,480 | 234,250 (0%) | 0% | 190.3 | 281,685 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 209.28 per share. | 07 Nov 2025 | 170 | 25,282 (0%) | 0% | 209.3 | 35,578 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 207.94 per share. | 07 Nov 2025 | 390 | 25,452 (0%) | 0% | 207.9 | 81,097 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 206.86 per share. | 07 Nov 2025 | 190 | 25,842 (0%) | 0% | 206.9 | 39,304 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 209.28 per share. | 07 Nov 2025 | 163 | 25,282 (0%) | 0% | 209.3 | 34,113 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 207.95 per share. | 07 Nov 2025 | 382 | 25,445 (0%) | 0% | 207.9 | 79,435 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 206.86 per share. | 07 Nov 2025 | 205 | 25,827 (0%) | 0% | 206.9 | 42,407 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 198.38 per share. | 07 Nov 2025 | 100 | 232,660 (0%) | 0% | 198.4 | 19,838 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 196.78 per share. | 07 Nov 2025 | 100 | 232,760 (0%) | 0% | 196.8 | 19,678 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 196.06 per share. | 07 Nov 2025 | 600 | 232,860 (0%) | 0% | 196.1 | 117,633 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 193.59 per share. | 07 Nov 2025 | 300 | 233,460 (0%) | 0% | 193.6 | 58,078 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 192.64 per share. | 07 Nov 2025 | 400 | 233,760 (0%) | 0% | 192.6 | 77,055 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 191.03 per share. | 07 Nov 2025 | 90 | 234,160 (0%) | 0% | 191.0 | 17,193 | Common Stock |
| Matthew Rabinowitz | Director, EXECUTIVE CHAIRMAN | Sale of securities on an exchange or to another person at price $ 200.29 per share. | 04 Nov 2025 | 17,198 | 2,286,554 (2%) | 0% | 200.3 | 3,444,565 | Common Stock |
| Matthew Rabinowitz | Director, EXECUTIVE CHAIRMAN | Sale of securities on an exchange or to another person at price $ 201.18 per share. | 04 Nov 2025 | 5,702 | 2,280,852 (2%) | 0% | 201.2 | 1,147,109 | Common Stock |
| Matthew Rabinowitz | Director, EXECUTIVE CHAIRMAN | Sale of securities on an exchange or to another person at price $ 200.00 per share. | 03 Nov 2025 | 17,100 | 2,303,752 (2%) | 0% | 200.0 | 3,420,003 | Common Stock |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Nov 2025 | 3,595 | 0 | - | - | Stock Option (right to buy) | |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Nov 2025 | 2,084 | 0 | - | - | Stock Option (right to buy) | |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Sale of securities on an exchange or to another person at price $ 200.00 per share. | 03 Nov 2025 | 156,573 | 144,816 (0%) | 0% | 200.0 | 31,314,334 | Common Stock |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Sale of securities on an exchange or to another person at price $ 198.96 per share. | 03 Nov 2025 | 1,915 | 301,389 (0%) | 0% | 199.0 | 381,012 | Common Stock |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Sale of securities on an exchange or to another person at price $ 198.03 per share. | 03 Nov 2025 | 2,215 | 303,304 (0%) | 0% | 198.0 | 438,635 | Common Stock |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Exercise or conversion of derivative security received from the company (such as an option) at price $ 119.75 per share. | 03 Nov 2025 | 150,000 | 305,519 (0%) | 0% | 119.8 | 17,962,500 | Common Stock |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Exercise or conversion of derivative security received from the company (such as an option) at price $ 13.01 per share. | 03 Nov 2025 | 2,084 | 151,924 (0%) | 0% | 13.0 | 27,113 | Common Stock |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Exercise or conversion of derivative security received from the company (such as an option) at price $ 20.27 per share. | 03 Nov 2025 | 3,595 | 155,519 (0%) | 0% | 20.3 | 72,871 | Common Stock |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Nov 2025 | 150,000 | 0 | - | - | Stock Option (right to buy) | |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 200.00 per share. | 03 Nov 2025 | 2,000 | 26,032 (0%) | 0% | 200 | 400,000 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 200.14 per share. | 03 Nov 2025 | 2,000 | 26,032 (0%) | 0% | 200.1 | 400,274 | Common Stock |
| Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | Sale of securities on an exchange or to another person at price $ 198.03 per share. | 03 Nov 2025 | 1,450 | 113,611 (0%) | 0% | 198.0 | 287,138 | Common Stock |
| Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | Sale of securities on an exchange or to another person at price $ 199.74 per share. | 03 Nov 2025 | 100 | 112,061 (0%) | 0% | 199.7 | 19,974 | Common Stock |
| Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | Sale of securities on an exchange or to another person at price $ 199.10 per share. | 03 Nov 2025 | 1,450 | 112,161 (0%) | 0% | 199.1 | 288,698 | Common Stock |
| Ruth W. Brinkley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Oct 2025 | 97 | 5,316 (0%) | 0% | - | Common Stock | |
| Roelof Frederik Botha | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Oct 2025 | 149 | 6,839 (0%) | 0% | - | Common Stock | |
| Roy D. Baynes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Oct 2025 | 93 | 18,359 (0%) | 0% | - | Common Stock | |
| Gail B. Marcus | Director | Sale of securities on an exchange or to another person at price $ 198.71 per share. | 31 Oct 2025 | 122 | 5,762 (0%) | 0% | 198.7 | 24,243 | Common Stock |
| Gail B. Marcus | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Oct 2025 | 121 | 5,884 (0%) | 0% | - | Common Stock | |
| Monica Bertagnolli | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Oct 2025 | 93 | 5,221 (0%) | 0% | - | Common Stock | |
| Rowan E. Chapman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Oct 2025 | 128 | 6,143 (0%) | 0% | - | Common Stock | |
| Herm Rosenman | Director | Sale of securities on an exchange or to another person at price $ 227.35 per share. | 31 Oct 2025 | 21,910 | 32,479 (0%) | 0% | 227.4 | 4,981,309 | Common Stock |
| Herm Rosenman | Director | Sale of securities on an exchange or to another person at price $ 228.49 per share. | 31 Oct 2025 | 11,987 | 20,492 (0%) | 0% | 228.5 | 2,738,859 | Common Stock |
| Herm Rosenman | Director | Sale of securities on an exchange or to another person at price $ 229.09 per share. | 31 Oct 2025 | 150 | 20,342 (0%) | 0% | 229.1 | 34,364 | Common Stock |
| Herm Rosenman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Oct 2025 | 132 | 68,761 (0%) | 0% | - | Common Stock | |
| Herm Rosenman | Director | Sale of securities on an exchange or to another person at price $ 226.62 per share. | 31 Oct 2025 | 14,372 | 54,389 (0%) | 0% | 226.6 | 3,256,945 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 192.32 per share. | 27 Oct 2025 | 288 | 235,921 (0%) | 0% | 192.3 | 55,389 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 191.46 per share. | 27 Oct 2025 | 191 | 235,730 (0%) | 0% | 191.5 | 36,569 | Common Stock |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 188.37 per share. | 27 Oct 2025 | 300 | 65,693 (0%) | 0% | 188.4 | 56,512 | Common Stock |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 192.20 per share. | 27 Oct 2025 | 200 | 65,993 (0%) | 0% | 192.2 | 38,439 | Common Stock |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 191.51 per share. | 27 Oct 2025 | 404 | 66,193 (0%) | 0% | 191.5 | 77,369 | Common Stock |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 189.90 per share. | 27 Oct 2025 | 574 | 66,597 (0%) | 0% | 189.9 | 109,001 | Common Stock |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 191.46 per share. | 27 Oct 2025 | 1,237 | 67,171 (0%) | 0% | 191.5 | 236,838 | Common Stock |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 192.32 per share. | 27 Oct 2025 | 781 | 68,408 (0%) | 0% | 192.3 | 150,205 | Common Stock |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 190.99 per share. | 27 Oct 2025 | 667 | 64,626 (0%) | 0% | 191.0 | 127,391 | Common Stock |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 192.12 per share. | 27 Oct 2025 | 500 | 64,126 (0%) | 0% | 192.1 | 96,058 | Common Stock |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 189.91 per share. | 27 Oct 2025 | 400 | 65,293 (0%) | 0% | 189.9 | 75,963 | Common Stock |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Sale of securities on an exchange or to another person at price $ 191.46 per share. | 27 Oct 2025 | 3,680 | 149,840 (0%) | 0% | 191.5 | 704,580 | Common Stock |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Sale of securities on an exchange or to another person at price $ 192.32 per share. | 27 Oct 2025 | 2,335 | 153,520 (0%) | 0% | 192.3 | 449,077 | Common Stock |
| Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | Sale of securities on an exchange or to another person at price $ 191.46 per share. | 27 Oct 2025 | 1,058 | 201,699 (0%) | 0% | 191.5 | 202,567 | Common Stock |
| Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | Sale of securities on an exchange or to another person at price $ 192.32 per share. | 27 Oct 2025 | 935 | 202,757 (0%) | 0% | 192.3 | 179,823 | Common Stock |
| Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | Sale of securities on an exchange or to another person at price $ 192.32 per share. | 27 Oct 2025 | 1,008 | 116,259 (0%) | 0% | 192.3 | 193,863 | Common Stock |
| Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | Sale of securities on an exchange or to another person at price $ 191.46 per share. | 27 Oct 2025 | 1,198 | 115,061 (0%) | 0% | 191.5 | 229,371 | Common Stock |
| John Fesko | PRESIDENT, CHIEF BUS. OFFICER | Sale of securities on an exchange or to another person at price $ 191.46 per share. | 27 Oct 2025 | 928 | 150,699 (0%) | 0% | 191.5 | 177,677 | Common Stock |
| John Fesko | PRESIDENT, CHIEF BUS. OFFICER | Sale of securities on an exchange or to another person at price $ 192.32 per share. | 27 Oct 2025 | 781 | 151,627 (0%) | 0% | 192.3 | 150,205 | Common Stock |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Oct 2025 | 1,250 | 0 | - | - | Restricted Stock Unit | |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 196.77 per share. | 22 Oct 2025 | 755 | 69,189 (0%) | 0% | 196.8 | 148,561 | Common Stock |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 187.16 per share. | 22 Oct 2025 | 495 | 69,944 (0%) | 0% | 187.2 | 92,644 | Common Stock |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Oct 2025 | 1,250 | 70,439 (0%) | 0% | - | Common Stock | |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 186.68 per share. | 22 Oct 2025 | 920 | 69,189 (0%) | 0% | 186.7 | 171,746 | Common Stock |
| Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | Sale of securities on an exchange or to another person at price $ 187.95 per share. | 21 Oct 2025 | 292 | 117,267 (0%) | 0% | 187.9 | 54,881 | Common Stock |
| John Fesko | PRESIDENT, CHIEF BUS. OFFICER | Sale of securities on an exchange or to another person at price $ 187.95 per share. | 21 Oct 2025 | 339 | 152,408 (0%) | 0% | 187.9 | 63,715 | Common Stock |
| Matthew Rabinowitz | Director, EXECUTIVE CHAIRMAN | Sale of securities on an exchange or to another person at price $ 190.00 per share. | 20 Oct 2025 | 10,000 | 5,000 (0%) | 0% | 190 | 1,900,000 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 187.95 per share. | 20 Oct 2025 | 93 | 236,209 (0%) | 0% | 187.9 | 17,479 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Oct 2025 | 190 | 236,302 (0%) | 0% | - | Common Stock | |
| Jonathan Sheena | Director, CO-FOUNDER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Oct 2025 | 190 | 191 | - | - | Restricted Stock Unit | |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Oct 2025 | 1,522 | 70,711 (0%) | 0% | - | Common Stock | |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Oct 2025 | 1,522 | 1,522 | - | - | Restricted Stock Unit | |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 187.95 per share. | 20 Oct 2025 | 602 | 70,109 (0%) | 0% | 188.0 | 113,146 | Common Stock |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Oct 2025 | 3,386 | 157,458 (0%) | 0% | - | Common Stock | |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Sale of securities on an exchange or to another person at price $ 187.95 per share. | 20 Oct 2025 | 1,603 | 155,855 (0%) | 0% | 188.0 | 301,284 | Common Stock |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Oct 2025 | 3,386 | 3,386 | - | - | Restricted Stock Unit | |
| Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | Sale of securities on an exchange or to another person at price $ 187.95 per share. | 20 Oct 2025 | 464 | 203,692 (0%) | 0% | 188.0 | 87,209 | Common Stock |
| Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Oct 2025 | 856 | 204,156 (0%) | 0% | - | Common Stock | |
| Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Oct 2025 | 856 | 856 | - | - | Restricted Stock Unit | |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 178.66 per share. | 15 Oct 2025 | 475 | 28,307 (0%) | 0% | 178.7 | 84,864 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 176.62 per share. | 15 Oct 2025 | 423 | 236,112 (0%) | 0% | 176.6 | 74,712 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 175.90 per share. | 15 Oct 2025 | 988 | 236,535 (0%) | 0% | 175.9 | 173,786 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 175.11 per share. | 15 Oct 2025 | 1,506 | 237,523 (0%) | 0% | 175.1 | 263,715 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 172.99 per share. | 15 Oct 2025 | 153 | 239,029 (0%) | 0% | 173.0 | 26,468 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 179.29 per share. | 15 Oct 2025 | 337 | 28,032 (0%) | 0% | 179.3 | 60,421 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 178.58 per share. | 15 Oct 2025 | 413 | 28,369 (0%) | 0% | 178.6 | 73,754 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 179.35 per share. | 15 Oct 2025 | 275 | 28,032 (0%) | 0% | 179.4 | 49,322 | Common Stock |
| Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | Sale of securities on an exchange or to another person at price $ 158.96 per share. | 01 Oct 2025 | 404 | 120,155 (0%) | 0% | 159.0 | 64,220 | Common Stock |
| Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | Sale of securities on an exchange or to another person at price $ 159.91 per share. | 01 Oct 2025 | 1,816 | 118,339 (0%) | 0% | 159.9 | 290,402 | Common Stock |
| Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | Sale of securities on an exchange or to another person at price $ 160.70 per share. | 01 Oct 2025 | 780 | 117,559 (0%) | 0% | 160.7 | 125,347 | Common Stock |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Sep 2025 | 6,250 | 71,680 (0%) | 0% | - | Common Stock | |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Sep 2025 | 6,250 | 0 | - | - | Restricted Stock Unit | |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 162.05 per share. | 29 Sep 2025 | 2,491 | 69,189 (0%) | 0% | 162.1 | 403,674 | Common Stock |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Sep 2025 | 18,750 | 177,264 (0%) | 0% | - | Common Stock | |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Sale of securities on an exchange or to another person at price $ 159.78 per share. | 29 Sep 2025 | 9,003 | 158,518 (0%) | 0% | 159.8 | 1,438,535 | Common Stock |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Sale of securities on an exchange or to another person at price $ 158.84 per share. | 29 Sep 2025 | 634 | 167,521 (0%) | 0% | 158.8 | 100,707 | Common Stock |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Sale of securities on an exchange or to another person at price $ 162.05 per share. | 29 Sep 2025 | 9,109 | 168,155 (0%) | 0% | 162.1 | 1,476,139 | Common Stock |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Sep 2025 | 18,750 | 0 | - | - | Restricted Stock Unit | |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Sale of securities on an exchange or to another person at price $ 161.47 per share. | 29 Sep 2025 | 470 | 154,072 (0%) | 0% | 161.5 | 75,892 | Common Stock |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Sale of securities on an exchange or to another person at price $ 160.49 per share. | 29 Sep 2025 | 3,976 | 154,542 (0%) | 0% | 160.5 | 638,099 | Common Stock |
| Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Sep 2025 | 2,500 | 0 | - | - | Restricted Stock Unit | |
| Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | Sale of securities on an exchange or to another person at price $ 162.05 per share. | 29 Sep 2025 | 1,364 | 203,300 (0%) | 0% | 162.1 | 221,040 | Common Stock |
| Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Sep 2025 | 2,500 | 204,664 (0%) | 0% | - | Common Stock | |
| Matthew Rabinowitz | Director, EXECUTIVE CHAIRMAN | Sale of securities on an exchange or to another person at price $ 181.28 per share. | 18 Sep 2025 | 1,188 | 2,320,852 (2%) | 0% | 181.3 | 215,363 | Common Stock |
| Matthew Rabinowitz | Director, EXECUTIVE CHAIRMAN | Sale of securities on an exchange or to another person at price $ 180.00 per share. | 18 Sep 2025 | 10,000 | 15,000 (0%) | 0% | 180 | 1,800,000 | Common Stock |
| Matthew Rabinowitz | Director, EXECUTIVE CHAIRMAN | Sale of securities on an exchange or to another person at price $ 180.13 per share. | 18 Sep 2025 | 14,473 | 2,346,379 (2%) | 0% | 180.1 | 2,607,069 | Common Stock |
| Matthew Rabinowitz | Director, EXECUTIVE CHAIRMAN | Sale of securities on an exchange or to another person at price $ 180.54 per share. | 18 Sep 2025 | 24,339 | 2,322,040 (2%) | 0% | 180.5 | 4,394,236 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 180.68 per share. | 17 Sep 2025 | 676 | 28,782 (0%) | 0% | 180.7 | 122,138 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 179.88 per share. | 17 Sep 2025 | 1,380 | 29,458 (0%) | 0% | 179.9 | 248,240 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 176.61 per share. | 17 Sep 2025 | 256 | 239,182 (0%) | 0% | 176.6 | 45,212 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 175.88 per share. | 17 Sep 2025 | 2,814 | 239,438 (0%) | 0% | 175.9 | 494,936 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 179.08 per share. | 17 Sep 2025 | 3,444 | 30,838 (0%) | 0% | 179.1 | 616,748 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 180.68 per share. | 17 Sep 2025 | 380 | 28,782 (0%) | 0% | 180.7 | 68,659 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 180.06 per share. | 17 Sep 2025 | 1,518 | 29,162 (0%) | 0% | 180.1 | 273,329 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 179.09 per share. | 17 Sep 2025 | 3,602 | 30,680 (0%) | 0% | 179.1 | 645,093 | Common Stock |
| Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | Gift of securities by or to the insider at price $ 0.00 per share. | 15 Sep 2025 | 300 | 120,559 (0%) | 0% | 0 | Common Stock | |
| Matthew Rabinowitz | Director, EXECUTIVE CHAIRMAN | Sale of securities on an exchange or to another person at price $ 170.31 per share. | 12 Sep 2025 | 4,500 | 25,500 (0%) | 0% | 170.3 | 766,387 | Common Stock |
| Matthew Rabinowitz | Director, EXECUTIVE CHAIRMAN | Sale of securities on an exchange or to another person at price $ 172.64 per share. | 12 Sep 2025 | 500 | 25,000 (0%) | 0% | 172.6 | 86,320 | Common Stock |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Sale of securities on an exchange or to another person at price $ 167.69 per share. | 02 Sep 2025 | 1,907 | 158,514 (0%) | 0% | 167.7 | 319,779 | Common Stock |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Sale of securities on an exchange or to another person at price $ 165.44 per share. | 02 Sep 2025 | 1,700 | 161,893 (0%) | 0% | 165.4 | 281,243 | Common Stock |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Sale of securities on an exchange or to another person at price $ 166.29 per share. | 02 Sep 2025 | 1,472 | 160,421 (0%) | 0% | 166.3 | 244,773 | Common Stock |
| Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | Sale of securities on an exchange or to another person at price $ 166.39 per share. | 02 Sep 2025 | 500 | 122,069 (0%) | 0% | 166.4 | 83,195 | Common Stock |
| Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | Sale of securities on an exchange or to another person at price $ 165.69 per share. | 02 Sep 2025 | 1,290 | 122,569 (0%) | 0% | 165.7 | 213,735 | Common Stock |
| Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | Sale of securities on an exchange or to another person at price $ 167.71 per share. | 02 Sep 2025 | 1,210 | 120,859 (0%) | 0% | 167.7 | 202,935 | Common Stock |
| Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | Sale of securities on an exchange or to another person at price $ 155.46 per share. | 12 Aug 2025 | 867 | 123,867 (0%) | 0% | 155.5 | 134,784 | Common Stock |
| Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | Sale of securities on an exchange or to another person at price $ 155.38 per share. | 12 Aug 2025 | 8 | 123,859 (0%) | 0% | 155.4 | 1,243 | Common Stock |
| Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Aug 2025 | 1,675 | 124,734 (0%) | 0% | - | Common Stock | |
| John Fesko | PRESIDENT, CHIEF BUS. OFFICER | Sale of securities on an exchange or to another person at price $ 155.33 per share. | 12 Aug 2025 | 6 | 152,747 (0%) | 0% | 155.3 | 932 | Common Stock |
| John Fesko | PRESIDENT, CHIEF BUS. OFFICER | Sale of securities on an exchange or to another person at price $ 155.46 per share. | 12 Aug 2025 | 672 | 152,753 (0%) | 0% | 155.5 | 104,469 | Common Stock |
| John Fesko | PRESIDENT, CHIEF BUS. OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Aug 2025 | 1,675 | 153,425 (0%) | 0% | - | Common Stock | |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 156.40 per share. | 08 Aug 2025 | 100 | 245,222 (0%) | 0% | 156.4 | 15,640 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 149.57 per share. | 08 Aug 2025 | 120 | 35,662 (0%) | 0% | 149.6 | 17,948 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 151.12 per share. | 08 Aug 2025 | 300 | 35,362 (0%) | 0% | 151.1 | 45,337 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 152.40 per share. | 08 Aug 2025 | 180 | 35,182 (0%) | 0% | 152.4 | 27,432 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 154.04 per share. | 08 Aug 2025 | 270 | 34,912 (0%) | 0% | 154.0 | 41,592 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 155.74 per share. | 08 Aug 2025 | 610 | 34,302 (0%) | 0% | 155.7 | 95,003 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 156.30 per share. | 08 Aug 2025 | 20 | 34,282 (0%) | 0% | 156.3 | 3,126 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 155.79 per share. | 08 Aug 2025 | 639 | 34,282 (0%) | 0% | 155.8 | 99,553 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 154.60 per share. | 08 Aug 2025 | 191 | 34,921 (0%) | 0% | 154.6 | 29,528 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 152.73 per share. | 08 Aug 2025 | 200 | 35,112 (0%) | 0% | 152.7 | 30,546 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 150.95 per share. | 08 Aug 2025 | 470 | 35,312 (0%) | 0% | 151.0 | 70,948 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 164.52 per share. | 08 Aug 2025 | 200 | 242,252 (0%) | 0% | 164.5 | 32,903 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 163.88 per share. | 08 Aug 2025 | 800 | 242,452 (0%) | 0% | 163.9 | 131,107 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 162.73 per share. | 08 Aug 2025 | 1,030 | 243,252 (0%) | 0% | 162.7 | 167,616 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 159.68 per share. | 08 Aug 2025 | 639 | 244,282 (0%) | 0% | 159.7 | 102,033 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 158.63 per share. | 08 Aug 2025 | 301 | 244,921 (0%) | 0% | 158.6 | 47,748 | Common Stock |
| Gail B. Marcus | Director | Sale of securities on an exchange or to another person at price $ 133.66 per share. | 01 Aug 2025 | 1,183 | 5,763 (0%) | 0% | 133.7 | 158,116 | Common Stock |
| Gail B. Marcus | Director | Sale of securities on an exchange or to another person at price $ 132.73 per share. | 01 Aug 2025 | 1,313 | 6,946 (0%) | 0% | 132.7 | 174,278 | Common Stock |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Sale of securities on an exchange or to another person at price $ 132.43 per share. | 01 Aug 2025 | 2,810 | 166,590 (0%) | 0% | 132.4 | 372,118 | Common Stock |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Sale of securities on an exchange or to another person at price $ 133.31 per share. | 01 Aug 2025 | 2,997 | 163,593 (0%) | 0% | 133.3 | 399,538 | Common Stock |
| Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | Sale of securities on an exchange or to another person at price $ 133.31 per share. | 01 Aug 2025 | 1,326 | 123,159 (0%) | 0% | 133.3 | 176,769 | Common Stock |
| Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | Sale of securities on an exchange or to another person at price $ 132.45 per share. | 01 Aug 2025 | 1,574 | 124,485 (0%) | 0% | 132.5 | 208,481 | Common Stock |
| Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | Sale of securities on an exchange or to another person at price $ 134.08 per share. | 01 Aug 2025 | 100 | 123,059 (0%) | 0% | 134.1 | 13,408 | Common Stock |
| Matthew Rabinowitz | Director, EXECUTIVE CHAIRMAN | Sale of securities on an exchange or to another person at price $ 139.81 per share. | 28 Jul 2025 | 1,718 | 2,360,852 (3%) | 0% | 139.8 | 240,191 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 139.81 per share. | 28 Jul 2025 | 479 | 245,322 (0%) | 0% | 139.8 | 66,968 | Common Stock |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 139.81 per share. | 28 Jul 2025 | 2,019 | 68,475 (0%) | 0% | 139.8 | 282,273 | Common Stock |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 138.01 per share. | 28 Jul 2025 | 1,278 | 65,430 (0%) | 0% | 138.0 | 176,380 | Common Stock |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 137.42 per share. | 28 Jul 2025 | 1,200 | 66,708 (0%) | 0% | 137.4 | 164,901 | Common Stock |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 136.01 per share. | 28 Jul 2025 | 567 | 67,908 (0%) | 0% | 136.0 | 77,116 | Common Stock |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Sale of securities on an exchange or to another person at price $ 139.81 per share. | 28 Jul 2025 | 6,092 | 169,400 (0%) | 0% | 139.8 | 851,712 | Common Stock |
| Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | Sale of securities on an exchange or to another person at price $ 139.81 per share. | 28 Jul 2025 | 1,994 | 202,164 (0%) | 0% | 139.8 | 278,778 | Common Stock |
| Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | Sale of securities on an exchange or to another person at price $ 139.81 per share. | 28 Jul 2025 | 2,206 | 126,059 (0%) | 0% | 139.8 | 308,417 | Common Stock |
| John Fesko | PRESIDENT, CHIEF BUS. OFFICER | Sale of securities on an exchange or to another person at price $ 139.81 per share. | 28 Jul 2025 | 1,710 | 151,750 (0%) | 0% | 139.8 | 239,072 | Common Stock |
| Herm Rosenman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jul 2025 | 153 | 68,629 (0%) | 0% | - | Common Stock | |
| Ruth W. Brinkley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jul 2025 | 112 | 5,219 (0%) | 0% | - | Common Stock | |
| Roelof Frederik Botha | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jul 2025 | 173 | 6,690 (0%) | 0% | - | Common Stock | |
| Roy D. Baynes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jul 2025 | 108 | 18,266 (0%) | 0% | - | Common Stock | |
| Gail B. Marcus | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jul 2025 | 141 | 8,259 (0%) | 0% | - | Common Stock | |
| Monica Bertagnolli | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jul 2025 | 108 | 5,128 (0%) | 0% | - | Common Stock | |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Jul 2025 | 1,250 | 1,250 | - | - | Restricted Stock Unit | |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 139.95 per share. | 22 Jul 2025 | 297 | 70,494 (0%) | 0% | 139.9 | 41,565 | Common Stock |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 139.20 per share. | 22 Jul 2025 | 458 | 70,791 (0%) | 0% | 139.2 | 63,755 | Common Stock |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 141.28 per share. | 22 Jul 2025 | 495 | 71,249 (0%) | 0% | 141.3 | 69,934 | Common Stock |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 139.58 per share. | 22 Jul 2025 | 920 | 70,494 (0%) | 0% | 139.6 | 128,415 | Common Stock |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Jul 2025 | 1,250 | 71,744 (0%) | 0% | - | Common Stock | |
| Jonathan Sheena | Director, CO-FOUNDER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jul 2025 | 190 | 245,894 (0%) | 0% | - | Common Stock | |
| Jonathan Sheena | Director, CO-FOUNDER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jul 2025 | 190 | 381 | - | - | Restricted Stock Unit | |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 139.29 per share. | 20 Jul 2025 | 93 | 245,801 (0%) | 0% | 139.3 | 12,954 | Common Stock |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jul 2025 | 1,522 | 3,044 | - | - | Restricted Stock Unit | |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 139.29 per share. | 20 Jul 2025 | 602 | 71,414 (0%) | 0% | 139.3 | 83,853 | Common Stock |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jul 2025 | 1,522 | 72,016 (0%) | 0% | - | Common Stock | |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jul 2025 | 3,386 | 6,772 | - | - | Restricted Stock Unit | |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Sale of securities on an exchange or to another person at price $ 139.29 per share. | 20 Jul 2025 | 1,622 | 175,492 (0%) | 0% | 139.3 | 225,928 | Common Stock |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jul 2025 | 3,386 | 177,114 (0%) | 0% | - | Common Stock | |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 149.96 per share. | 16 Jul 2025 | 3,070 | 245,704 (0%) | 0% | 150.0 | 460,388 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 159.22 per share. | 02 Jul 2025 | 200 | 37,082 (0%) | 0% | 159.2 | 31,845 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 160.11 per share. | 02 Jul 2025 | 1,092 | 35,990 (0%) | 0% | 160.1 | 174,835 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 161.23 per share. | 02 Jul 2025 | 208 | 35,782 (0%) | 0% | 161.2 | 33,535 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 161.29 per share. | 02 Jul 2025 | 189 | 35,782 (0%) | 0% | 161.3 | 30,483 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 160.11 per share. | 02 Jul 2025 | 1,011 | 35,971 (0%) | 0% | 160.1 | 161,869 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 159.14 per share. | 02 Jul 2025 | 300 | 36,982 (0%) | 0% | 159.1 | 47,742 | Common Stock |
| Gail B. Marcus | Director | Sale of securities on an exchange or to another person at price $ 167.56 per share. | 01 Jul 2025 | 2,651 | 8,118 (0%) | 0% | 167.6 | 444,189 | Common Stock |
| Gail B. Marcus | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 24.42 per share. | 01 Jul 2025 | 4,299 | 12,417 (0%) | 0% | 24.4 | 104,982 | Common Stock |
| Gail B. Marcus | Director | Sale of securities on an exchange or to another person at price $ 167.05 per share. | 01 Jul 2025 | 1,648 | 10,769 (0%) | 0% | 167.1 | 275,301 | Common Stock |
| Gail B. Marcus | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2025 | 4,299 | 0 | - | - | Stock Option (right to buy) | |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Sale of securities on an exchange or to another person at price $ 164.00 per share. | 01 Jul 2025 | 1,008 | 178,063 (0%) | 0% | 164.0 | 165,308 | Common Stock |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Sale of securities on an exchange or to another person at price $ 167.77 per share. | 01 Jul 2025 | 648 | 173,728 (0%) | 0% | 167.8 | 108,714 | Common Stock |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Sale of securities on an exchange or to another person at price $ 167.19 per share. | 01 Jul 2025 | 3,187 | 174,376 (0%) | 0% | 167.2 | 532,839 | Common Stck |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Sale of securities on an exchange or to another person at price $ 165.83 per share. | 01 Jul 2025 | 500 | 177,563 (0%) | 0% | 165.8 | 82,917 | Common Stock |
| Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | Sale of securities on an exchange or to another person at price $ 167.79 per share. | 01 Jul 2025 | 291 | 130,205 (0%) | 0% | 167.8 | 48,827 | Common Stock |
| Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | Sale of securities on an exchange or to another person at price $ 163.88 per share. | 01 Jul 2025 | 400 | 132,805 (0%) | 0% | 163.9 | 65,551 | Common Stock |
| Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | Sale of securities on an exchange or to another person at price $ 165.98 per share. | 01 Jul 2025 | 200 | 132,605 (0%) | 0% | 166.0 | 33,197 | Common Stock |
| Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | Sale of securities on an exchange or to another person at price $ 167.25 per share. | 01 Jul 2025 | 2,109 | 130,496 (0%) | 0% | 167.2 | 352,730 | Common Stock |
| Herm Rosenman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jun 2025 | 271 | 68,476 (0%) | 0% | - | Common Stock | |
| Herm Rosenman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jun 2025 | 2,143 | 68,205 (0%) | 0% | - | Common Stock | |
| Ruth W. Brinkley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jun 2025 | 2,143 | 5,107 (0%) | 0% | - | Common Stock | |
| Roelof Frederik Botha | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jun 2025 | 2,143 | 6,246 (0%) | 0% | - | Common Stock | |
| Roelof Frederik Botha | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jun 2025 | 271 | 6,517 (0%) | 0% | - | Common Stock | |
| Roy D. Baynes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jun 2025 | 2,143 | 18,158 (0%) | 0% | - | Common Stock | |
| Gail B. Marcus | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jun 2025 | 271 | 8,118 (0%) | 0% | - | Common Stock | |
| Gail B. Marcus | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jun 2025 | 2,143 | 7,847 (0%) | 0% | - | Common Stock | |
| Monica Bertagnolli | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jun 2025 | 2,143 | 5,020 (0%) | 0% | - | Common Stock | |
| Rowan E. Chapman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jun 2025 | 149 | 8,765 (0%) | 0% | - | Common Stock | |
| Rowan E. Chapman | Director | Sale of securities on an exchange or to another person at price $ 166.99 per share. | 27 Jun 2025 | 2,750 | 6,015 (0%) | 0% | 167.0 | 459,223 | Common Stock |
| Rowan E. Chapman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jun 2025 | 271 | 8,616 (0%) | 0% | - | Common Stock | |
| Rowan E. Chapman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jun 2025 | 2,143 | 8,345 (0%) | 0% | - | Common Stock | |
| Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | Sale of securities on an exchange or to another person at price $ 170.18 per share. | 18 Jun 2025 | 10,000 | 213,674 (0%) | 0% | 170.2 | 1,701,795 | Common Stock |
| Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | Sale of securities on an exchange or to another person at price $ 170.63 per share. | 18 Jun 2025 | 7,630 | 206,044 (0%) | 0% | 170.6 | 1,301,911 | Common Stock |
| Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Jun 2025 | 856 | 204,622 (0%) | 0% | - | Common Stock | |
| Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Jun 2025 | 856 | 1,712 | - | - | Restricted Stock Unit | |
| Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | Sale of securities on an exchange or to another person at price $ 139.29 per share. | 18 Jun 2025 | 464 | 204,158 (0%) | 0% | 139.3 | 64,631 | Common Stock |
| Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | Sale of securities on an exchange or to another person at price $ 171.50 per share. | 18 Jun 2025 | 2,278 | 203,766 (0%) | 0% | 171.5 | 390,671 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 164.81 per share. | 16 Jun 2025 | 550 | 37,829 (0%) | 0% | 164.8 | 90,644 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 164.64 per share. | 16 Jun 2025 | 425 | 37,981 (0%) | 0% | 164.6 | 69,972 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 163.10 per share. | 16 Jun 2025 | 200 | 38,406 (0%) | 0% | 163.1 | 32,620 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 162.52 per share. | 16 Jun 2025 | 176 | 38,606 (0%) | 0% | 162.5 | 28,603 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 165.48 per share. | 16 Jun 2025 | 547 | 37,282 (0%) | 0% | 165.5 | 90,519 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 163.41 per share. | 16 Jun 2025 | 203 | 38,379 (0%) | 0% | 163.4 | 33,172 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 167.29 per share. | 16 Jun 2025 | 3,070 | 248,774 (0%) | 0% | 167.3 | 513,571 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 162.50 per share. | 16 Jun 2025 | 200 | 38,582 (0%) | 0% | 162.5 | 32,499 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 165.41 per share. | 16 Jun 2025 | 699 | 37,282 (0%) | 0% | 165.4 | 115,620 | Common Stock |
| Gail B. Marcus | Director | Sale of securities on an exchange or to another person at price $ 164.33 per share. | 10 Jun 2025 | 3,400 | 6,304 (0%) | 0% | 164.3 | 558,734 | Common Stock |
| Gail B. Marcus | Director | Sale of securities on an exchange or to another person at price $ 165.04 per share. | 10 Jun 2025 | 600 | 5,704 (0%) | 0% | 165.0 | 99,027 | Common Stock |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Sale of securities on an exchange or to another person at price $ 156.07 per share. | 02 Jun 2025 | 1,512 | 183,670 (0%) | 0% | 156.1 | 235,972 | Common Stock |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Sale of securities on an exchange or to another person at price $ 158.33 per share. | 02 Jun 2025 | 1,476 | 179,071 (0%) | 0% | 158.3 | 233,688 | Common Stock |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Sale of securities on an exchange or to another person at price $ 157.03 per share. | 02 Jun 2025 | 3,123 | 180,547 (0%) | 0% | 157.0 | 490,403 | Common Stock |
| Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | Sale of securities on an exchange or to another person at price $ 156.30 per share. | 02 Jun 2025 | 1,290 | 134,915 (0%) | 0% | 156.3 | 201,629 | Common Stock |
| Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | Sale of securities on an exchange or to another person at price $ 159.12 per share. | 02 Jun 2025 | 100 | 133,205 (0%) | 0% | 159.1 | 15,912 | Common Stock |
| Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | Sale of securities on an exchange or to another person at price $ 158.37 per share. | 02 Jun 2025 | 465 | 133,305 (0%) | 0% | 158.4 | 73,643 | Common Stock |
| Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | Sale of securities on an exchange or to another person at price $ 157.23 per share. | 02 Jun 2025 | 1,145 | 133,770 (0%) | 0% | 157.2 | 180,028 | Common Stock |
| Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | Sale of securities on an exchange or to another person at price $ 139.29 per share. | 27 May 2025 | 291 | 128,265 (0%) | 0% | 139.3 | 40,533 | Common Stock |
| Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | Sale of securities on an exchange or to another person at price $ 156.85 per share. | 27 May 2025 | 1,649 | 128,556 (0%) | 0% | 156.9 | 258,646 | Common Stock |
| John Fesko | PRESIDENT, CHIEF BUS. OFFICER | Sale of securities on an exchange or to another person at price $ 139.29 per share. | 27 May 2025 | 339 | 153,460 (0%) | 0% | 139.3 | 47,219 | Common Stock |
| John Fesko | PRESIDENT, CHIEF BUS. OFFICER | Sale of securities on an exchange or to another person at price $ 156.85 per share. | 27 May 2025 | 1,438 | 153,799 (0%) | 0% | 156.9 | 225,551 | Common Stock |
| Matthew Rabinowitz | Director, EXECUTIVE CHAIRMAN | Sale of securities on an exchange or to another person at price $ 153.10 per share. | 15 May 2025 | 9,000 | 55,000 (0%) | 0% | 153.1 | 1,377,900 | Common Stock |
| Matthew Rabinowitz | Director, EXECUTIVE CHAIRMAN | Sale of securities on an exchange or to another person at price $ 153.90 per share. | 15 May 2025 | 10,000 | 45,000 (0%) | 0% | 153.9 | 1,539,000 | Common Stock |
| Matthew Rabinowitz | Director, EXECUTIVE CHAIRMAN | Sale of securities on an exchange or to another person at price $ 161.00 per share. | 15 May 2025 | 10,000 | 35,000 (0%) | 0% | 161 | 1,610,000 | Common Stock |
| Matthew Rabinowitz | Director, EXECUTIVE CHAIRMAN | Sale of securities on an exchange or to another person at price $ 165.85 per share. | 15 May 2025 | 5,000 | 30,000 (0%) | 0% | 165.9 | 829,250 | Common Stock |
| Matthew Rabinowitz | Director, EXECUTIVE CHAIRMAN | Sale of securities on an exchange or to another person at price $ 150.20 per share. | 15 May 2025 | 10,000 | 74,000 (0%) | 0% | 150.2 | 1,502,000 | Common Stock |
| Matthew Rabinowitz | Director, EXECUTIVE CHAIRMAN | Sale of securities on an exchange or to another person at price $ 152.60 per share. | 15 May 2025 | 10,000 | 64,000 (0%) | 0% | 152.6 | 1,526,000 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 153.95 per share. | 09 May 2025 | 392 | 254,522 (0%) | 0% | 153.9 | 60,348 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 159.01 per share. | 09 May 2025 | 708 | 38,782 (0%) | 0% | 159.0 | 112,577 | Common Stock |